https://www.lymedisease.org/nh-lyme-insurance-bill/

TOUCHED BY LYME: New Hampshire Lyme insurance bill heads to governor

 

 

 

 

 

https://events-na4.adobeconnect.com/content/connect/c1/841425677/en/events/event/shared/1741061809/event_registration.  Register Here

Wednesday 8 July 2020, 08:00 AM – 07:00 PM

The Fourteenth Meeting of the Tick-Borne Disease Working Group (TBDWG) will be held on July 8, 2020, from 9:00 a.m. to 8:00 p.m., Eastern Time. This is an on-line meeting and everyone is welcome to attend.

For this fourteenth meeting, the TBDWG will review the draft 2020 report to the HHS Secretary and Congress and review and approve graphics and images for the report. The 2020 report will address ongoing tick-borne disease research, including research related to causes, prevention, treatment, surveillance, diagnosis, diagnostics, and interventions for individuals with tick-borne diseases; advances made pursuant to such research; federal activities related to tick-borne diseases; and gaps in tick-borne disease research. A full agenda will be posted on the website prior to the meeting.

Public comment may be provided verbally or in writing. Thirty minutes has been set aside for verbal comments. Persons who wish to provide verbal or written comments should review directions at the Tick-Borne Disease Working Group website.

Written comments and requests to make verbal comments must be received by midnight Wednesday, June 24, 2020, Eastern Time to be included in the public record.

For additional information about the meeting, please visit the Tick-Borne Disease Working Group website.

 

 

 

 

 

https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext

Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Henry Ford COVID-19 Task Force

Highlights

  • As of May27, 2020 there are over 1,678,843 confirmed cases of COVID-19 claiming more than 100,000 lives in the Unites States. Currently there is no known effective therapy or vaccine.
  • According to a protocol-based treatment algorithm, among hospitalized patients, use of hydroxychloroquine alone and in combination with azithromycin was associated with a significant reduction in-hospital mortality compared to not receiving hydroxychloroquine.
  • Findings of this observational study provide crucial data on experience with hydroxychloroquine therapy, providing necessary interim guidance for COVID-19 therapeutic practice.

Abstract

Significance

The United States is in an acceleration phase of the COVID-19 pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS-CoV-2, highlighting urgency around identifying effective therapies.

Objective

The purpose of this study was to evaluate the role of hydroxychloroquine therapy alone and in combination with azithromycin in hospitalized patients positive for COVID-19.

Design

Multi-center retrospective observational study

Setting

The Henry Ford Health System (HFHS) in Southeast Michigan: large six hospital integrated health system; the largest of hospitals is an 802-bed quaternary academic teaching hospital in urban Detroit, Michigan.

Participants

Consecutive patients hospitalized with a COVID-related admission in the health system from March 10,2020 to May 2,2020 were included. Only the first admission was included for patients with multiple admissions. All patients evaluated were 18 years of age and older and were treated as inpatients for at least 48 hours unless expired within 24 hours.

Exposure

Receipt of hydroxychloroquine alone, hydroxychloroquine in combination with azithromycin, azithromycin alone, or neither.

Main Outcome

The primary outcome was in-hospital mortality.

Results

Of 2,541 patients, with a median total hospitalization time of 6 days (IQR: 4-10 days), median age was 64 years (IQR:53-76 years), 51% male, 56% African American, with median time to follow-up of 28.5 days (IQR:3-53). Overall in-hospital mortality was 18.1% (95% CI:16.6%-19.7%); by treatment: hydroxychloroquine + azithromycin, 157/783 (20.1% [95% CI: 17.3%-23.0%]), hydroxychloroquine alone, 162/1202 (13.5% [95% CI: 11.6%-15.5%]), azithromycin alone, 33/147 (22.4% [95% CI: 16.0%-30.1%]), and neither drug, 108/409 (26.4% [95% CI: 22.2%-31.0%])​.
Primary cause of mortality was respiratory failure (88%); no patient had documented torsades de pointes. From Cox regression modeling, predictors of mortality were age>65 years (HR:2.6 [95% CI:1.9-3.3]), white race (HR:1.7 [95% CI:1.4-2.1]), CKD (HR:1.7 [95%CI:1.4-2.1]), reduced O2 saturation level on admission (HR:1.5 [95%CI:1.1-2.1]), and ventilator use during admission (HR: 2.2 [95%CI:1.4-3.3]). Hydroxychloroquine provided a 66% hazard ratio reduction, and hydroxychloroquine + azithromycin 71% compared to neither treatment (p < 0.001).

Conclusions and Relevance

In this multi-hospital assessment, when controlling for COVID-19 risk factors, treatment with hydroxychloroquine alone and in combination with azithromycin was associated with reduction in COVID-19 associated mortality. Prospective trials are needed to examine this impact.
_____________________
Excerpt:
Dr. Meryl Nass has uncovered a hornet’s nest of government sponsored Hydroxychloroquine experiments that were designed to kill severely ill, Covid-19 hospitalized patients. On June 14th Dr. Nass first identified two Covid-19 experiments in which massive, high toxic doses – four times higher than safeof hydroxychloroquine were being given to severely ill hospitalized patients in intensive care units.

Regarding the anti-viral Remdesivir:  https://madisonarealymesupportgroup.com/2020/07/02/remdesivir-for-covid-19-not-backed-by-results/

Excerpt: 

Remdesivir isn’t cheap.  In fact, this article states it costs $320 per vial and will be sold for $3,120 per 6 vial treatment:  https://www.thegatewaypundit.com/2020/06/stunning-faucis-remdesivir-costs-9-per-dose-will-sold-3000-per-dose-china-company-linked-soros-will-also-mass-produce-drug/ That’s a lot of money for a drug that hasn’t even been shown to lower viral load.

Hydroxychloroquine in the other hand costs $1 per treatment, while chloroquine costs a measly 30 cents!  https://madisonarealymesupportgroup.com/2020/05/11/podcast-evidence-supporting-hcq-azithromycin-for-covid-19/

The article also points out an ugly conflict of interest web between Gilead, the manufacturer of Remdesivir and UNITAID which Soros, Gates, and the Clinton Health Access Initiative, are large investors – with Drs. Fauci and Birx associated with the Clinton Health Access initiative.  And of course, Dr. Fauci has worked with Gilead for a long, long time. Government employees should not be allowed to have financial ties to manufacturing companies and then turn around and make public health policy.

 https://principia-scientific.org/a-tale-of-2-drugs-deep-state-chose-money-power-over-lives/

Excerpt:

Approximately $70 million in U.S. taxpayer funding began Gilead’s partnership with the U.S. Army, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to develop remdesivir. Initially for treating Ebola, it failed to show benefit and was shelved. If remdesivir is used to treat COVID-19, Gilead shareholders, not the taxpayers, will profit.

https://pubmed.ncbi.nlm.nih.gov/32560202/

Interrupted Blood Feeding in Ticks: Causes and Consequences

Affiliations expand

Free article

Abstract

Ticks are obligate hematophagous arthropods and act as vectors for a great variety of pathogens, including viruses, bacteria, protozoa, and helminths. Some tick-borne viruses, such as Powassan virus and tick-borne encephalitis virus, are transmissible within 15-60 min after tick attachment. However, a minimum of 3-24 h of tick attachment is necessary to effectively transmit bacterial agents such as Ehrlichia spp., Anaplasma spp., and Rickettsia spp. to a new host. Longer transmission periods were reported for Borrelia spp. and protozoans such as Babesia spp., which require a minimum duration of 24-48 h of tick attachment for maturation and migration of the pathogen.

Laboratory observations indicate that the probability of transmission of tick-borne pathogens increases with the duration an infected tick is allowed to remain attached to the host. However, the transmission time may be shortened when partially fed infected ticks detach from their initial host and reattach to a new host, on which they complete their engorgement.

For example, early transmission of tick-borne pathogens (e.g., Rickettsia rickettsii, Borrelia burgdorferi, and Brucella canis) and a significantly shorter transmission time were demonstrated in laboratory experiments by interrupted blood feeding.

The relevance of such situations under field conditions remains poorly documented.

In this review, we explore parameters of, and causes leading to, spontaneous interrupted feeding in nature, as well as the effects of this behavior on the minimum time required for transmission of tick-borne pathogens.

____________________

**Comment**

Partial feeding is not rare and needs to be taken into account. Unfortunately, authorities have followed a tightly controlled narrative when it comes to transmission times – which has only served to hurt patients for decades.

There are cases where Lyme (borrelia) has been transmitted within hours:  https://madisonarealymesupportgroup.com/2016/12/07/igenex-presentation/

Excerpt:

Bob Giguere of IGeneX states a case by Dr. Jones of a little girl who went outside to play about 8:30a.m. and came inside at 10:30 with an attached tick above her right eye.  By 2 o’clock, she had developed the facial palsy.  At the hospital she was told it couldn’t be Lyme as the tick hadn’t been attached long enough.  They offered a neuro-consult…..

By 4pm she couldn’t walk or talk.

Do not believe what the “experts” tell you about transmission times!

Authorities also talk about ticks having a “grace period” before they transmit which is hog-wash:  https://madisonarealymesupportgroup.com/2020/03/10/grace-period-for-ticks-nope/

For more:  https://madisonarealymesupportgroup.com/2017/04/14/transmission-time-for-lymemsids-infection/

https://madisonarealymesupportgroup.com/2019/04/26/three-strains-of-borrelia-other-pathogens-found-in-salivary-glands-of-ixodes-ticks-suggesting-quicker-transmission-time/

https://madisonarealymesupportgroup.com/2019/11/14/study-shows-ticks-can-transmit-rickettsia-immediately/

https://madisonarealymesupportgroup.com/2017/06/28/powassan-can-kill/

 

 

 

 

https://chroniclymediseasesummit4.com/

LYME20_banner_attend_600x600

Don’t miss The Chronic Lyme Disease Summit 4

Now considered to be a dysfunction of the immune system, Lyme disease can mimic other chronic conditions; it can manifest in autoimmunity… along with other misunderstood chronic conditions, Lyme disease has destroyed people’s lives. 

Lyme disease can be a devastating (and sometimes hidden) condition, but it doesn’t have to be! Known as “The Great Imitator,” Lyme disease may mimic other chronic health conditions: arthritis, fibromyalgia, chronic fatigue syndrome, MS, depression…

But the sooner it’s detected, the easier it is to address!

—>>Gain a deeper understanding of Lyme disease when you attend this complimentary, online event!

Lyme disease is difficult to diagnose and treat and has over 150 different possible symptoms: fatigue, mood problems, insomnia, neurological impairments, brain fog, migraines, gut issues, neuropathy, joint pain and others. If not properly treated, over time Lyme disease becomes chronic and can manifest in autoimmunity or a number of other degenerative, debilitating health issues.

Some people live in a cycle of symptom management while remaining extremely ill.
Many doctors don’t know which medications to give people, so many have to find their own solutions.

The fact is: if you don’t know the root cause of your health issues, it’s so much harder to heal.

WHY ATTEND?
Your host, Dr. Jay Davidson, nearly lost his wife to chronic Lyme disease, which prompted him to undergo years of research to help her heal. He’ll share that wisdom with you during this summit.

Lean on the wisdom of our health experts to help with:
+ Testing methods and treatment protocols
+ Steps to take before addressing Lyme
+ Staying empowered in the doctor/patient relationship
+ Supporting mitochondrial health and drainage
+ Detox and diet protocols
+ Nutrition, exercise and mindset strategies
+ And so much more!

Register for free

or

Order Presentation to gift someone else or watch at your own convenience.

If you’ve been diagnosed with or suspect you’ve been misdiagnosed, it’s time to gain a deeper understanding of Lyme disease!

Join us at this important event to discover current research and novel approaches to testing and treating chronic Lyme disease and what you can do to boost your immune system health.

You’re not alone. There are answers. We can heal together.

P.S. When you register for The Chronic Lyme Disease Summit 4k, you’ll also unlock early-access interviews, complimentary guides and helpful eBooksabout living your most resilient life!

 

___________________

**Comment**

Just for clarification: ALL disease is basically due to an impaired immune system from the standpoint of if the immune system was working at 100% it would be able to fight off disease.  Tick-borne illness by nature causes immune dysfunction as these are pathogens who work synergistically together and literally feast upon the human body, depriving it of vital nutrients.  Of course replacing those nutrients and building blocks is essential but in my opinion only one prong of treatment.  Detoxification is another prong, and antimicrobial treatment is the third important prong.

When we only focus on the immune system we miss a key of the puzzle and that is the pathogens themselves – which typically means antimicrobial treatment of one form or another.

From my experience, when the pathogens are dealt with, many if not most symptoms just disappear.

There’s always exceptions.  I’ve personally heard stories of people getting well on nothing but supportive things like diet and supplements; however, they are in the minority.  I get excited over each and every person who finds wholeness – no matter how it comes, but at the end of the day we all must make informed choices and nobody knows your body better than you do. You must gather all the information you can and choose for yourself your course of action.  All I can say is “God speed” on whatever you choose and may you reach the other side.

For more on treatment:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

https://madisonarealymesupportgroup.com/2020/06/26/new-treatments-for-lyme-disease-on-the-horizon/

https://madisonarealymesupportgroup.com/2019/02/22/why-mainstream-lyme-msids-research-remains-in-the-dark-ages/ This article is based upon an important video Dr. Burrascano did where he shares nuances of successful treatment. Blood levels of antimicrobials are important (dosage) as well as cycling (going off treatment when you’ve been symptom-free for 2-3 months and then hitting it hard with antimicrobials if and when you relapse.  He’s found that doing 3-4 cycles has brought people to remission).

Some of the sickest patients I’ve seen are 1) those who have had it for decades 2) used antimicrobials (typically antibiotics) indiscriminately.  It takes a trained eye and know-how to treat this.  You can NOT just throw more and more doxycycline at this.  It takes many antimicrobials and varying dosages (depending upon the person) in a layered fashion.  You have to deal with all forms of Bb (borrelia or Lyme) as well as every coinfection, which can include worms.